<DOC>
	<DOCNO>NCT02724059</DOCNO>
	<brief_summary>The study include 30 patient hilar/mediastinal lymph node detect thoracic CT either know lung malignancy ( stag purpose ) ( diagnose purpose ) . All patient undergo EBUS-guided TBNA . Elastography perform lymph node candidate EBUS TBNA . Mediastinoscopy invasive procedure perform EBUS-guided TBNA n't provide representative material .</brief_summary>
	<brief_title>The Role Endobronchial Ultrasound Elastography Diagnosis Mediastinal Lesions</brief_title>
	<detailed_description>All patient subject follow parameter : 1 . Thorough history take full clinical examination . 2 . Chest X-ray ( postro-anterior lateral view ) procedure . 3 . Recent Computed Tomography ( CT chest ) contrast . 4 . Laboratory study : - Complete liver function . - Blood urea serum creatinine . - Complete blood picture ( include platelet count ) . - Erythrocyte sedimentation rate ( ESR ) . - Fasting postprandial blood sugar . 5 . Preoperative evaluation : Pulmonary function test ( PFT ) , Electrocardiogram ( ECG ) , arterial blood gas ( ABG ) coagulation profile ( include bleed &amp; clot time , prothrombin time &amp; activity activate partial thromboplastin time ( APTT ) ) oral anticoagulant stop procedure least 48 hour . 6 . Color doppler ultrasound suspect vascular lesion . 7 . Clinical radiological follow patient 1 week procedure detect occurrence complication . 8 . The biopsy sample examine histopathologically . EBUS-guided TBNA examination perform case pulmonary department Tanta University Educational Hospital outpatient procedure dedicate bronchoscopy suit Pantex EBUS probe Hitachi ultrasound 7.5 MHz , BF-UC160F ( Olympus Optical Co. , Tokyo , Japan , approve FDA ) convex probe bronchoscope EU C2000 processor ( Olympus , Tokyo , Japan ) oral route supine position local anesthesia lidocaine conscious sedation intravenous midazolam . Lymph node identify accord Mountain 's regional lymph node classification system ( 5 ) . The lymph node station 2 , 4 , 7 , 10 11 evaluate systematically . After appearance target lymph node , diameter , shape , edge definition , internal echo distribution , location lymph node record conventional B mode ultrasound . Elastography perform lymph node candidate EBUS TBNA . The scan range include entire lymph node surround normal tissue . Elastographic B mode image simultaneously displayed side side monitor . Elastographic pattern describe accord dominant color distribution within target lymph node . The strain ratio measure good contact appropriate compression transducer achieve , indicate elastography image ultrasound processor . The large possible area node outline superimposed elastography image ; procedure perform similar‑sized area surround apparently normal tissue . The ultrasound processor measure strain area quantitative figure , strain ratio two area calculate . The strain ratio record minimum 3 time prior EBUS‑TBNA . The mean recording also calculate . ( 4 ) After elastography , EBUS TBNA perform Cook 22 gauge needle ( c976006 , Cook Ireland Limited Liability Company , Ireland ) . The number pass per patient record . N3 node sample first N2 node avoid contamination lung cancer patient . Histological cytological specimen collect sent laboratory subsequent analysis pathologist blind elastography value . Aspiration specimen consider `` insufficient '' adequate number lymphocyte smear . A definitive diagnosis malignancy EBUS TBNA specimens consider positive result . No clear evidence malignancy inadequate specimen EBUS TBNA deem negative result . For patient whose result negative malignancy , invasive procedure mediastinoscopy do confirm diagnosis radiologic follow-up outcome LNs least 6 month . On follow-up , LNs persist size , diminish , resolve consider benign . A diagnosis tuberculosis sarcoidosis make base cytopathology show presence caseate noncaseating granuloma , addition clinical , radiological , microbiological finding .</detailed_description>
	<criteria>Hilar/mediastinal lymph node short axis 1 cm thoracic CT scan and/or PETCT suspicious malignancy without know lung malignancy . Hilar and/or mediastinal lymph node positive PET/CT scan without regard diameter suspicious malignancy . Recurrence restaging NSCLC chemotherapy radiation . Diagnosis benign malignant mediastinal lesion . Cardiovascular instability . Lack patient cooperation , e.g . intractable cough , inability remain motionless altered consciousness . Bleeding diathesis ( activate partial thromboplastin time ( APTT ) ratio international normalize ratio ( INR ) &lt; 1.3 platelet count &lt; 50000 per mm3 ) . Border line respiratory failure patient mechanical ventilation . Severe chronic obstructive pulmonary disease ( COPD ) ( FEV1 &lt; 1 liter &lt; 35 % predict ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>